Quick Takeaways
- This page summarizes Jon Snodgres's Form 4 filing for REPLIGEN CORP (RGEN).
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 28 Feb 2022, 18:10.
Jon Snodgres - 24 Feb 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)
- Signature
- /s/ Kimberly Brown (Attorney in Fact)
- Issuer symbol
- RGEN
- Transactions as of
- 24 Feb 2022
- Net transactions value
- -$50,897
- Form type
- 4
- Filing time
- 28 Feb 2022, 18:10:51 UTC
- Previous filing
- 22 Feb 2022
- Next filing
- 02 Mar 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Jon Snodgres filed Form 4 for REPLIGEN CORP (RGEN) on 28 Feb 2022."
What Changed
- Previous filing in this sequence was filed on 22 Feb 2022.
- Current net transaction value: -$50,897.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGEN | Common Stock | Award | $0 | +3,443 | +11% | $0.000000 | 33,904 | 24 Feb 2022 | Direct | F1 |
| transaction | RGEN | Common Stock | Tax liability | $50,897 | -269 | -0.79% | $189.21 | 33,635 | 24 Feb 2022 | Direct | F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGEN | Stock Option (Right to Buy) | Award | $0 | +4,410 | $0.000000 | 4,410 | 24 Feb 2022 | Common Stock | 4,410 | $189.21 | Direct | F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Mr. Snodgres was awarded 3,443 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
| F2 | Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
| F3 | One third of the stock options will vest and become exercisable annually on February 24, 2023, February 24, 2024 and February 24, 2025. |